Max Robotics — Global Service Robot Directory + US Certification

About

En-Chi Hsu is a pioneering researcher in the emerging field of biohybrid microrobotics, where living organisms are integrated with synthetic materials to create next-generation biomedical tools. Her work centers on developing living cell-based robots for precision medicine, with a particular focus on overcoming therapeutic challenges like tumor hypoxia. Hsu’s most influential contribution is the development of "Volbots"—microalgae-based robots derived from *Volvox* that enable multimode precision imaging and therapy, a breakthrough paper that has garnered 49 citations since 2022. She has also advanced the acoustic fabrication of living cardiomyocyte-based hybrid biorobots, a 2022 study with 37 citations that introduced rapid, functional assembly methods for bioinspired actuators. By addressing the limitations of passive assembly techniques, Hsu’s work enables more sophisticated designs for biorobotic systems. Her research sits at the intersection of microrobotics, tissue engineering, and cancer therapy, offering transformative approaches for targeted drug delivery. With her innovative use of microalgae and cardiac cells, Hsu is shaping the future of biohybrid robotics, making her a rising star in this interdisciplinary field.